These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25048271)

  • 1. Influence of lifestyle modifications on age-related free radical injury to brain.
    Peskind ER; Li G; Shofer JB; Millard SP; Leverenz JB; Yu CE; Raskind MA; Quinn JF; Galasko DR; Montine TJ
    JAMA Neurol; 2014 Sep; 71(9):1150-4. PubMed ID: 25048271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased cerebrospinal fluid F2-isoprostanes are associated with aging and latent Alzheimer's disease as identified by biomarkers.
    Montine TJ; Peskind ER; Quinn JF; Wilson AM; Montine KS; Galasko D
    Neuromolecular Med; 2011 Mar; 13(1):37-43. PubMed ID: 20632131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-sectional and longitudinal relationships between cerebrospinal fluid biomarkers and cognitive function in people without cognitive impairment from across the adult life span.
    Li G; Millard SP; Peskind ER; Zhang J; Yu CE; Leverenz JB; Mayer C; Shofer JS; Raskind MA; Quinn JF; Galasko DR; Montine TJ
    JAMA Neurol; 2014 Jun; 71(6):742-51. PubMed ID: 24756381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. History of cigarette smoking in cognitively-normal elders is associated with elevated cerebrospinal fluid biomarkers of oxidative stress.
    Durazzo TC; Mattsson N; Weiner MW; Korecka M; Trojanowski JQ; Shaw LM;
    Drug Alcohol Depend; 2014 Sep; 142():262-8. PubMed ID: 25037769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations.
    Lautner R; Insel PS; Skillbäck T; Olsson B; Landén M; Frisoni GB; Herukka SK; Hampel H; Wallin A; Minthon L; Hansson O; Blennow K; Mattsson N; Zetterberg H
    Alzheimers Res Ther; 2017 Oct; 9(1):87. PubMed ID: 29061195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F2-isoprostanes in Alzheimer and other neurodegenerative diseases.
    Montine TJ; Montine KS; McMahan W; Markesbery WR; Quinn JF; Morrow JD
    Antioxid Redox Signal; 2005; 7(1-2):269-75. PubMed ID: 15650414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
    Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J
    PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid abeta42, tau, and f2-isoprostane concentrations in patients with Alzheimer disease, other dementias, and in age-matched controls.
    Montine TJ; Kaye JA; Montine KS; McFarland L; Morrow JD; Quinn JF
    Arch Pathol Lab Med; 2001 Apr; 125(4):510-2. PubMed ID: 11260625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Racial Disparities in Biomarkers for Alzheimer Disease.
    Morris JC; Schindler SE; McCue LM; Moulder KL; Benzinger TLS; Cruchaga C; Fagan AM; Grant E; Gordon BA; Holtzman DM; Xiong C
    JAMA Neurol; 2019 Mar; 76(3):264-273. PubMed ID: 30615028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers.
    Durazzo TC; Korecka M; Trojanowski JQ; Weiner MW; O' Hara R; Ashford JW; Shaw LM;
    J Alzheimers Dis; 2016 Jul; 54(1):99-107. PubMed ID: 27472882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in cerebrospinal fluid F2-isoprostanes is related to cognitive decline in APOE ε4 carriers.
    Duits FH; Kester MI; Scheffer PG; Blankenstein MA; Scheltens P; Teunissen CE; van der Flier WM
    J Alzheimers Dis; 2013; 36(3):563-70. PubMed ID: 23629585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span.
    Jack CR; Wiste HJ; Weigand SD; Knopman DS; Vemuri P; Mielke MM; Lowe V; Senjem ML; Gunter JL; Machulda MM; Gregg BE; Pankratz VS; Rocca WA; Petersen RC
    JAMA Neurol; 2015 May; 72(5):511-9. PubMed ID: 25775353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F2-isoprostanes: a measure of oxidative stress in children receiving treatment for leukemia.
    Hockenberry MJ; Taylor OA; Gundy PM; Ross AK; Pasvogel A; Montgomery D; Ribbeck P; McCarthy K; Moore I
    Biol Res Nurs; 2014 Jul; 16(3):303-9. PubMed ID: 23956352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major metabolite of F2-isoprostane in urine may be a more sensitive biomarker of oxidative stress than isoprostane itself.
    Dorjgochoo T; Gao YT; Chow WH; Shu XO; Yang G; Cai Q; Rothman N; Cai H; Li H; Deng X; Franke A; Roberts LJ; Milne G; Zheng W; Dai Q
    Am J Clin Nutr; 2012 Aug; 96(2):405-14. PubMed ID: 22760572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease risk factors and oxidative stress among premenopausal women.
    Anderson C; Milne GL; Park YM; Sandler DP; Nichols HB
    Free Radic Biol Med; 2018 Feb; 115():246-251. PubMed ID: 29229550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients.
    Ikizler TA; Morrow JD; Roberts LJ; Evanson JA; Becker B; Hakim RM; Shyr Y; Himmelfarb J
    Clin Nephrol; 2002 Sep; 58(3):190-7. PubMed ID: 12356187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid biomarkers for neuropsychological symptoms in early stage of late-onset Alzheimer's disease.
    Kuo HC; Yen HC; Huang CC; Hsu WC; Wei HJ; Lin CL
    Int J Neurosci; 2015; 125(10):747-54. PubMed ID: 25290083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased F3-Isoprostanes in the Canadian Inuit Population Could Be Cardioprotective by Limiting F2-Isoprostane Production.
    Alkazemi D; Jackson RL; Chan HM; Kubow S
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3264-71. PubMed ID: 27192695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.